Drawing for RARENOTE

USPTO serial 79289208

RARENOTE

Reviewed by CopyMark Law Group

Reg. 6366864Status 700Renewal
Filing date
Status date
Registration date
Jun 1, 2021
Examiner
WOLFE, YOUNG J
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with RARENOTE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $797*

Plus Government fees of $975

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Yoon S. Ham

Yoon S. Ham Hauptman Ham, LLP2318 Mill RoadSuite 1400Alexandria, VA 22314

Goods and services

ClassDescriptionStatusFirst use
009Downloadable computer software in the health field, namely, downloadable software for medical billing for physicians and health care institutions; Recorded computer software for use as an application programming interface for multifunction health devices for recording health status; Recorded wireless terminal intelligent application program, namely, recorded application programming interface software for wireless point of sale terminals for making contactless payments; Downloadable computer software applications that allows patients who suffer from the same diseases and symptoms to communicate with each other via an online forum; Downloadable multimedia file containing text, audio, and video featuring information on treatment for cancer, and rare disease, namely, inherited retinal diseases, Lysosomal storage diseases, motor neuron disease, neurocutaneous disorder, and connective tissue disorder; Downloadable smartphone application software for medical billing; Downloadable electronic publications in the nature of articles in the field of cancer, and rare disease, namely, inherited retinal diseases, Lysosomal storage diseases, motor neuron disease, neurocutaneous disorder, and connective tissue disorder; Consumer coupons downloaded from a global computer network; Downloadable computer search engine software; Downloadable computer software for receiving, processing, transmitting, and displaying data; Downloadable application software for storing data using blockchain technology; Downloadable application software for smart phones, namely, downloadable mobile applications for providing information about recruiting patients for participation in clinical trials for the testing of drugs; Downloadable smartphone application software for medical billing for physicians and health care institutions; Downloadable smartphone application software for medical and health information provision, namely, downloadable interactive multimedia software featuring audio and video information for patients on the subject of treatments, procedures, and alternatives related to cancer, and rare disease, namely, inherited retinal diseases, Lysosomal storage diseases, motor neuron disease, neurocutaneous disorder, and connective tissue disorder; Downloadable computer software for medical and health database management; Downloadable computer software for processing and management of medical data, namely, downloadable software for use in medical database management; Downloadable application software for smartphones for data collection in the medical field; Downloadable medical electronic chart computer software, namely, downloadable software for recording and transmitting medical data charts; Downloadable computer software for use in medical disease diagnosis; Downloadable application software for use with a smartphone for the purpose of collecting patient health dataACTIVE—
038Electronic transmission of health care data and health care information; Electronic bulletin board services for social network services related to health care; Electronic transmission and streaming of digital media content for others via global and local computer networks; Electronic exchange of messages among computer users via online chat lines, online chatrooms and Internet forums; Streaming of digital media content for others on the Internet; Electronic digital messaging services; Providing Internet access to online multimedia content; Providing on-line chatrooms for the transmission of messages, comments and multimedia content among users; Providing user access to online search engines via smart phone applications; Leasing of online telecommunication equipment, namely, equipment used for receiving, forwarding, and transmitting medical digital images; Providing internet chatrooms for providing medical information; Electronic bulletin board services that enable connection to a variety of thematic information and opinions via internet; Providing Internet access to health care data and health care database through computers and medical devices; Streaming of audio, visual and audiovisual material via a cloud-based computer network; Providing Internet access to online healthcare platforms, namely, online healthcare forums; Communication services, namely, transmitting medical information between patients and health care providers via internet servers; Providing access to mobile internet platforms in the nature of online forums for patient communities; Providing Internet access to online platforms used for collecting patient health data; Providing Internet access to online platforms used for collecting medical information related to rare diseasesACTIVE—
044Medical services relating to DNA; Genetic testing for medical purposes; Medical analysis services relating to the treatment of persons; Provision of health information; Providing health care information via a global computer network; Medical analysis for the diagnosis and treatment of persons; Provision of medical information from a web site; Medical and health care services; Medical analysis of human biodata for medical purposes; Providing information about fat stem cells for medical purposes via an online database; Genetic counseling for medical purposes; Provision of medical information; Providing information in the field of medicine; Medical information services provided via the Internet; Medical analysis relating to clinical data for diagnostic and treatment purposes; Individual medical counselling services provided to patients; Providing information about genetics for patient health checkups; Medical advisory services for patients of rare diseasesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 1, 2026REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Feb 11, 2023NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jan 21, 2022ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Oct 25, 2021FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Sep 24, 2021FICSFINAL DISPOSITION NOTICE SENT TO IB—
Sep 24, 2021FIMPFINAL DISPOSITION PROCESSED—
Sep 1, 2021FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jun 1, 2021R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Apr 28, 2021LIMNLIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED—
Apr 11, 2021LIMGLIMITATION OF GOODS RECEIVED FROM IB—
Mar 16, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 16, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 15, 2021GPNXNOTIFICATION PROCESSED BY IB—
Feb 24, 2021OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Feb 24, 2021OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Feb 24, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 5, 2021NREPNEW REPRESENTATIVE AT IB RECEIVED—
Feb 5, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 3, 2021XAECEXAMINER'S AMENDMENT ENTERED—
Feb 3, 2021GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Feb 3, 2021GNEAEXAMINERS AMENDMENT E-MAILED—
Feb 3, 2021CNEAEXAMINERS AMENDMENT -WRITTEN—
Jan 14, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 14, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 7, 2021ALIEASSIGNED TO LIE—
Sep 28, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 27, 2020RFNTREFUSAL PROCESSED BY IB—
Sep 16, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Sep 16, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Sep 16, 2020ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Sep 16, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 16, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Sep 16, 2020COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Sep 5, 2020RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Aug 25, 2020RFRRREFUSAL PROCESSED BY MPU—
Jul 19, 2020RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jul 18, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 14, 2020MAFRAPPLICATION FILING RECEIPT MAILED—
Jul 10, 2020DOCKASSIGNED TO EXAMINER—
Jul 10, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 9, 2020REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance